INVO Fertility Files Proxy Materials
Ticker: IVF · Form: DEFA14A · Filed: Jun 23, 2025 · CIK: 1417926
Sentiment: neutral
Topics: proxy-statement, corporate-governance, sec-filing
TL;DR
INVO Fertility just dropped proxy docs, shareholder vote incoming.
AI Summary
INVO Fertility, Inc. filed a Definitive Additional Materials proxy statement on June 23, 2025. This filing relates to the company's proxy materials, indicating a shareholder meeting or vote is upcoming. The company, formerly known as NAYA Biosciences, Inc., is incorporated in Nevada and operates in the surgical and medical instruments sector.
Why It Matters
This filing signals upcoming shareholder decisions or meetings for INVO Fertility, Inc., which could impact corporate governance and future strategic direction.
Risk Assessment
Risk Level: low — This is a routine proxy filing and does not inherently introduce new risks to the company or its investors.
Key Players & Entities
- INVO Fertility, Inc. (company) — Registrant
- NAYA Biosciences, Inc. (company) — Former company name
- 20250623 (date) — Filing date
FAQ
What is the purpose of this DEFA14A filing?
This filing is a Definitive Additional Materials proxy statement, indicating it supplements previously filed proxy materials for INVO Fertility, Inc.
When was this filing submitted to the SEC?
The filing was submitted on June 23, 2025.
What is INVO Fertility, Inc.'s former name?
INVO Fertility, Inc. was formerly known as NAYA Biosciences, Inc., with a name change effective October 22, 2024.
In which state is INVO Fertility, Inc. incorporated?
INVO Fertility, Inc. is incorporated in Nevada (NV).
What is the company's primary business sector?
The company operates in the 'Surgical & Medical Instruments & Apparatus' sector, with SIC code 3841.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on June 23, 2025 regarding INVO Fertility, Inc. (IVF).